FDA review of dupilumab for chronic spontaneous urticaria

Published Date: 13 Mar 2023

The FDA approval request for CSU is based on data from a pair of Phase 3 trials in two different populations.

Read Full News

Latest News


News All Time

Featured News
Featured Articles
Featured Events
Featured KOL Videos

1.

Older Men Increasingly Overtreated for Prostate Cancer, Study Suggests

2.

Vaccine shows promise for pancreatic cancer, study finds

3.

Mezigdomide Combinations Show Promise in Multiple Myeloma

4.

Spouses of Cancer Patients May Be at Increased Risk of Suicide

5.

Patients With Melanoma Brain Mets May Fare Better With RT Before Immunotherapy


© Copyright 2026 Hidoc Dr. Inc.

Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation
bot